Predilife S.A. (ENXTPA: ALPRE)
Health Care · Biotechnology · FR
€1.11
-25.50% today · -66.0% 1Y
Predilife S.A. (ENXTPA: ALPRE) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.11M and employs 21 people.
Over the last twelve months the share price has lost 66.0%, trading between 0.90 and 4.00.
Tweenvest scores Predilife S.A. across four factors: quality 6/100, value 46/100, growth 100/100. Its strongest factor is growth.
ALPRE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.11M
- Revenue (TTM)
- $981.34K
- P/E
- —
- EPS
- -1.00
- Dividend yield
- —
- Beta (5Y)
- 0.25
- 52-week high
- €4.00
- 52-week low
- €0.90
- Avg volume (3M)
- —
- Shares outstanding
- 3.95M
- Employees
- 21
- Next earnings
- —
About Predilife S.A.
Founded in 2004 and headquartered in Villejuif, France, Predilife S.A. specializes in devising and commercializing sophisticated medical technologies and analytical models. The company's core offerings include preventative healthcare solutions and comprehensive breast screening tests. Among its notable products are MammoRisk, a diagnostic tool designed to forecast an individual's risk of developing breast cancer; DenSeeMammo, software for evaluating breast tissue density; and a specialized medical device developed for predicting prostate cancer risk.
- ISIN
- FR0010169920
- Founded
- 2004
- Listed since
- Dec 21, 2018
- Exchange
- Euronext Paris
- Currency
- EUR
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $266.00 | +0.08% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.45 | +0.05% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.10 | -0.45% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $551.33 | -0.27% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €903.40 | +2.75% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $155.95 | -1.81% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.